FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

126115000: Norgestimate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
13078018 Norgestimate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
730036014 Norgestimate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3226691000005116 norgestimat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Norgestimate Is a Syntetisk steroid false Inferred relationship Some
Norgestimate Is a Progesterone false Inferred relationship Some
Norgestimate Is a Synthetic progestogen (substance) true Inferred relationship Some
Norgestimate Is a Drug allergen false Inferred relationship Some
Norgestimate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Progestational hormone false Inferred relationship Some
Norgestimate Is a Steroid hormone true Inferred relationship Some
Norgestimate Is a Norsteroid true Inferred relationship Some
Norgestimate Is a Progestationelt hormon false Inferred relationship Some
Norgestimate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Progesterone receptor agonist (disposition) true Inferred relationship Some
Norgestimate Is a Estrane true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing norgestimate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Norgestimate Inferred relationship Some 1
Norgestimate [combined oc] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Norgestimate Inferred relationship Some
estradiol 1 mg + estradiol 1 mg + norgestimat 0,09 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Norgestimate Inferred relationship Some
Ethinyl estradiol + norgestimate 0.035mg/0.25mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Norgestimate Inferred relationship Some
Ethinylestradiol 35 microgram and norgestimate 180 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Norgestimate Inferred relationship Some
Product containing ethinylestradiol and norgestimate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Norgestimate Inferred relationship Some 2
Ethinylestradiol 35 microgram and norethisterone 500 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Norgestimate Inferred relationship Some
ethinylestradiol 35 µg + norethisteron 1 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Norgestimate Inferred relationship Some
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Norgestimate Inferred relationship Some
Product containing precisely ethinylestradiol 35 microgram and norgestimate 215 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Norgestimate Inferred relationship Some
Ethinylestradiol 35 microgram and norgestimate 180 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Norgestimate Inferred relationship Some 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 215 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Norgestimate Inferred relationship Some 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 215 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Norgestimate Inferred relationship Some 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Norgestimate Inferred relationship Some 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Norgestimate Inferred relationship Some 1
Ethinylestradiol 35 microgram and norgestimate 180 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Norgestimate Inferred relationship Some 2
Ethinylestradiol 35 microgram and norgestimate 180 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Norgestimate Inferred relationship Some 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 215 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Norgestimate Inferred relationship Some 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Norgestimate Inferred relationship Some 1
Ethinylestradiol 35 microgram and norgestimate 180 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Norgestimate Inferred relationship Some 1
Product containing ethinylestradiol and norgestimate in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Norgestimate Inferred relationship Some 2
Ethinylestradiol and norgestimate only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Norgestimate Inferred relationship Some 2
Product containing only norgestimate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Norgestimate Inferred relationship Some 1
Product containing only ethinylestradiol and norgestimate in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Norgestimate Inferred relationship Some 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Norgestimate Inferred relationship Some 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Norgestimate Inferred relationship Some 2
Ethinylestradiol 35 microgram and norgestimate 180 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Norgestimate Inferred relationship Some 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 215 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Norgestimate Inferred relationship Some 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 215 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Norgestimate Inferred relationship Some 2

This concept is not in any reference sets

Back to Start